161 related articles for article (PubMed ID: 12790323)
21. Microscopic tumor cell dissemination in gastric cancer.
Jonas S; Weinrich M; Tullius SG; Al-Abadi H; Steinbrich R; Radke C; Klupp J; Neuhaus P
Surg Today; 2004; 34(2):101-6. PubMed ID: 14745607
[TBL] [Abstract][Full Text] [Related]
22. [Isolated tumor cells in bone marrow predicts reduced survival in lymph node-negative non-small-cell lung cancer].
Passlick B; Kubuschok B; Izbicki JR; Thetter O; Pantel K
Pneumologie; 2000 Aug; 54(8):355-60. PubMed ID: 11008478
[TBL] [Abstract][Full Text] [Related]
23. [Establishment of risk evaluation model of peritoneal metastasis in gastric cancer and its predictive value].
Zhao J; Zhou R; Zhang Q; Shu P; Li H; Wang X; Shen Z; Liu F; Chen W; Qin J; Sun Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Jan; 20(1):47-52. PubMed ID: 28105619
[TBL] [Abstract][Full Text] [Related]
24. Micrometastases in bone marrow: prognostic indicators for pancreatic cancer.
Roder JD; Thorban S; Pantel K; Siewert JR
World J Surg; 1999 Sep; 23(9):888-91. PubMed ID: 10449815
[TBL] [Abstract][Full Text] [Related]
25. [Minimal Residual Disease (MRD) in gastric carcinoma--an overview].
Garlipp B; Steinert R; Lippert H; Meyer F
Z Gastroenterol; 2011 Feb; 49(2):225-33. PubMed ID: 21298608
[TBL] [Abstract][Full Text] [Related]
26. [Minimal residual disease in gastrointestinal tumors: tumor detection in bone marrow, blood and lymph nodes].
Rosenberg R; Nekarda H; Thorban S; Siewert JR
Acta Med Austriaca Suppl; 2002; 59():42-53. PubMed ID: 12506760
[TBL] [Abstract][Full Text] [Related]
27. Immunohistochemical assessment of individual tumor cells in lymph nodes of patients with non-small-cell lung cancer.
Passlick B; Izbicki JR; Kubuschok B; Nathrath W; Thetter O; Pichlmeier U; Schweiberer L; Riethmüller G; Pantel K
J Clin Oncol; 1994 Sep; 12(9):1827-32. PubMed ID: 8083707
[TBL] [Abstract][Full Text] [Related]
28. Urokinase system expression in gastric carcinoma: prognostic impact in an independent patient series and first evidence of predictive value in preoperative biopsy and intestinal metaplasia specimens.
Beyer BC; Heiss MM; Simon EH; Gruetzner KU; Babic R; Jauch KW; Schildberg FW; Allgayer H
Cancer; 2006 Mar; 106(5):1026-35. PubMed ID: 16435385
[TBL] [Abstract][Full Text] [Related]
29. Prognostic value of nodal micrometastases in patients with cancer of the gastro-oesophageal junction.
Heeren PA; Kelder W; Blondeel I; van Westreenen HL; Hollema H; Plukker JT
Eur J Surg Oncol; 2005 Apr; 31(3):270-6. PubMed ID: 15780562
[TBL] [Abstract][Full Text] [Related]
30. Morphological and immunohistochemical characterization of isolated tumor cells by p53 status in gastrointestinal tumors.
Milsmann C; Füzesi L; Heinmöller E; Krause P; Werner C; Becker H; Horstmann O
Langenbecks Arch Surg; 2008 Jan; 393(1):49-58. PubMed ID: 17876601
[TBL] [Abstract][Full Text] [Related]
31. [Clinical significance and efficacy of conversion surgery for patients with stage IV gastric cancer].
Zhu Z
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Oct; 21(10):1087-1092. PubMed ID: 30370504
[TBL] [Abstract][Full Text] [Related]
32. [Prognostic factors of lymph node-negative metastasis gastric cancer].
Sun D; Xu H; Huang J
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Feb; 20(2):190-194. PubMed ID: 28226354
[TBL] [Abstract][Full Text] [Related]
33. Analysis Of Risk Factors Of Positive Peritoneal Cytology In Patients Treated For Gastric Cancer--Preliminary Report.
Lisiecki R; Spychała A; Pater K; Murawa D
Pol Przegl Chir; 2015 Oct; 87(10):506-12. PubMed ID: 26812751
[TBL] [Abstract][Full Text] [Related]
34. Micrometastases in axillary lymph nodes and bone marrow of lymph node-negative breast cancer patients--prognostic relevance after 10 years.
Gebauer G; Fehm T; Merkle E; Jaeger W; Mitze M
Anticancer Res; 2003; 23(5b):4319-24. PubMed ID: 14666645
[TBL] [Abstract][Full Text] [Related]
35. Prognostic relevance of circulating tumor cells in blood and disseminated tumor cells in bone marrow of patients with squamous cell carcinoma of the oral cavity.
Gröbe A; Blessmann M; Hanken H; Friedrich RE; Schön G; Wikner J; Effenberger KE; Kluwe L; Heiland M; Pantel K; Riethdorf S
Clin Cancer Res; 2014 Jan; 20(2):425-33. PubMed ID: 24218516
[TBL] [Abstract][Full Text] [Related]
36. The 'Sentinel Node' Concept: More Questions Raised than Answers Provided?
Schlag PM
Oncologist; 1998; 3(5):VI-VII. PubMed ID: 10388128
[TBL] [Abstract][Full Text] [Related]
37. Clinical relevance of occult tumor cells in lymph nodes from gastric cancer patients.
Doekhie FS; Mesker WE; van Krieken JH; Kok NF; Hartgrink HH; Kranenbarg EK; Putter H; Kuppen PJ; Tanke HJ; Tollenaar RA; van de Velde CJ
Am J Surg Pathol; 2005 Sep; 29(9):1135-44. PubMed ID: 16096401
[TBL] [Abstract][Full Text] [Related]
38. [Simultaneous immunocytochemical detection of tumor cells in lymph nodes and in bone marrow of patients with resectable bronchial carcinomas].
Passlick B; Pantel K; Kubuschok B; Izbicki JR; Thetter O
Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):21-4. PubMed ID: 14518204
[TBL] [Abstract][Full Text] [Related]
39. Micrometastases in non-small cell lung cancer (NSCLC).
Passlick B
Lung Cancer; 2001 Dec; 34 Suppl 3():S25-9. PubMed ID: 11740989
[TBL] [Abstract][Full Text] [Related]
40. Prognostic impact of micrometastatic tumor cells in the lymph nodes and bone marrow of patients with completely resected stage I non-small-cell lung cancer.
Osaki T; Oyama T; Gu CD; Yamashita T; So T; Takenoyama M; Sugio K; Yasumoto K
J Clin Oncol; 2002 Jul; 20(13):2930-6. PubMed ID: 12089221
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
